Can mothers with diabetes consume Panax notoginseng powder during lactation?

Aug 22, 2022 Source: Cainiu Health
Dr. Pan Yongyuan
Introduction
Women with diabetes who are breastfeeding should not consume *Panax notoginseng* (Sanqi). This is because *Panax notoginseng* has blood-activating and stasis-resolving effects; if ingested by the mother, its active components may be excreted into breast milk and subsequently transferred to the infant. Since infants’ liver and kidney functions are not yet fully developed, they cannot adequately metabolize these compounds, potentially impairing normal growth and development. Breastfeeding women requiring medication should always consult a qualified healthcare professional and must not self-medicate.

The lactation period is a special phase for breastfeeding mothers. To ensure the healthy growth and development of their babies, mothers must pay attention to many aspects—especially diet. So, can mothers with diabetes consume Sanqi (Panax notoginseng) powder during lactation?

Can mothers with diabetes consume Sanqi powder during lactation?

Mothers with diabetes should avoid Sanqi during lactation. Sanqi possesses blood-activating and stasis-resolving properties; if ingested by the mother, its active components may pass into breast milk. Since infants’ liver and kidney functions are still immature, they cannot adequately metabolize these compounds, potentially impairing normal growth and development. Lactating women who require medication should always consult a qualified healthcare professional before initiating any treatment—self-medication is strongly discouraged.

Regarding diabetes management during lactation: if blood glucose levels are only mildly elevated, patients may achieve glycemic control through dietary modifications and appropriate physical activity. However, if blood glucose levels are significantly high, pharmacologic intervention becomes necessary. Insulin therapy is generally recommended for lactating women, as it is considered safer than most oral hypoglycemic agents. Many oral antidiabetic drugs can be excreted into breast milk, posing potential risks to the infant. Therefore, oral hypoglycemic agents are generally not advised during lactation. Insulin offers greater safety and allows flexible dose adjustments based on the mother’s real-time blood glucose monitoring.

If feasible, mothers with diabetes should consider weaning their infants as early as appropriate. For those opting to switch to formula feeding, insulin therapy may be discontinued and replaced with oral hypoglycemic agents, which may offer greater convenience. We hope this information has been helpful. Wishing you good health and happiness!